Author

J. Pietruska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. L. Bayer· 2 shared P. W. Hinds· 2 shared J. Farrell· 1 shared P. Alcaide· 1 shared P. Tsichlis· 1 shared S. K. McRee· 1 shared S. McRee· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. L. Bayer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

S. K. McRee, A. L. Bayer, J. Pietruska, P. Tsichlis, P. W. Hinds

This study shows AKT2 promotes melanoma metastasis while AKT1 is critical for tumor initiation, suggesting AKT2 as a therapeutic target in BRAF-mutant melanoma.

bioRxiv · Aug 24, 2023 · PreprintCancer Biology

AKT1 is Required for a Complete Palbociclib-induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma

A. L. Bayer, J. Pietruska, J. Farrell, S. McRee, P. Alcaide, P. W. Hinds

This study shows AKT1 is required for Palbociclib-induced senescence in BRAF-V600E melanoma cells, acting through NF-kB but not cGAS-STING.

bioRxiv · Dec 2, 2021Cancer Biology